e-Drug3D

976

CAPREOMYCIN

DISCONTINUED


INN
CAPREOMYCIN

cas 11003-38-6
CLASS

ANTIINFECTIVES
MACROLIDE
TUBERCULOSTATIC
ANTIFUNGAL
ANTIBIOTIC
ANTIBACTERIAL

ROUTE (list)

INJECTION

ATC code

J04AB30

PK parameters

Tmax 1.5 HOUR

Solubility

SOLUBLE IN WATER


Target

TARGET 50S RIBOSOMAL PROTEIN L10

DrugCentral

Unknown

Download SDF file (3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-3,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide

Formula:
C25H44N14O8

Calculated chemical properties:

MW 668.74
NB_atoms 47
XLogP -8.03
PSA 330.588
NB_HD 19
NB_HA 22
fsp3 0.60
Lipinski(0=no;1=yes) 0

FDA
NDA 050095 (pdf not found) INN (CAPREOMYCIN SULFATE) CAPASTAT SULFATE (EPIC PHARMA LLC) APPROVAL= AP YEAR= 1971 DISCONTINUED
NDA 202634 (pdf not found) INN (CAPREOMYCIN SULFATE) CAPREOMYCIN SULFATE (NORVIUM BIOSCIENCE) APPROVAL= AP YEAR= 2017 DISCONTINUED
NDA 204796 (pdf not found) INN (CAPREOMYCIN SULFATE) CAPREOMYCIN SULFATE (HISUN PHARM HANGZHOU) APPROVAL= AP YEAR= 2018 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL